Clinical Trial Update: A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

BioNTech is conducting a Phase 1/2 trial to evaluate the safety and efficacy of the investigational combination of BNT324 and BNT327 in patients with advanced l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• BNT324
• BNT327

Snippet

Sponsor: BioNTech SE | Conditions: Advanced Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING